Gastrointestinal Stromal Tumor (GIST) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Conditions: Advanced Gastrointestinal Stromal Tumors; Metastatic Cancer Interventions: Drug: CGT9486 plus sunitinib; Drug: CGT9486; Drug: Sunitinib Sponsor: Cogent Biosciences, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2022 Category: Research Source Type: clinical trials
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Conditions: Advanced Gastrointestinal Stromal Tumors; Metastatic Cancer Interventions: Drug: CGT9486 plus sunitinib; Drug: CGT9486; Drug: Sunitinib Sponsor: Cogent Biosciences, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2022 Category: Research Source Type: clinical trials
Safety of Laparoscopic Resection for Gastrointestinal Stromal Tumor on Unfavorable Anatomic Site of Stomach
Condition: Gastrointestinal Stromal Tumors Intervention: Procedure: Laparoscopic resection Sponsors: RenJi Hospital; Nanfang Hospital of Southern Medical University; Beijing Cancer Hospital; Shanghai Zhongshan Hospital; The First Affiliated Hospital with Nanjing Medical University; Fujian Medical University Union Hospital; Peking University People's Hospital; Ruijin Hospital; Wuhan Union Hospital, China; West China Hospital; First Affiliated Hospital, Sun Yat-Sen University; Liaoning Cancer Hospital & Institute; Chinese PLA General Hospital...
Source: ClinicalTrials.gov - January 20, 2022 Category: Research Source Type: clinical trials
A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Conditions: Gastrointestinal Stromal Tumors (GIST); Neoplasms, Connective Tissue; Neoplasms, Connective and Soft Tissue; Neoplasms by Histologic Type; Neoplasms; Gastrointestinal Neoplasms; Digestive System Neoplasm; Digestive System Disease; Gastrointestinal Diseas es Intervention: Drug: THE-630 Sponsor: Theseus Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2021 Category: Research Source Type: clinical trials
